Evidence map›Paper›PMID 26762397›Full record

ArticlePflugers Archiv : European journal of physiology2016

Adult nephron-specific MR-deficient mice develop a severe renal PHA-1 phenotype.

Jérémie Canonica, Chloé Sergi, Marc Maillard, Petra Klusonova, Alex Odermatt, Robert Koesters, Dominique Loffing-Cueni, Johannes Loffing, Bernard Rossier, Simona Frateschi and 1 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Aldosterone-independent regulation of K + secretion in the distal nephron.Current opinion in nephrology and hypertension · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Potassium homeostasis: sensors, mediators, and targets.Pflugers Archiv : European journal of physiology · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Emerging Targets of Diuretic Therapy.Clinical pharmacology and therapeutics · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jérémie CanonicaDepartment of Pharmacology and Toxicology, University of Lausanne, Rue du Bugnon 27, CH-1011, Lausanne, Switzerland.
Chloé SergiDepartment of Pharmacology and Toxicology, University of Lausanne, Rue du Bugnon 27, CH-1011, Lausanne, Switzerland.
Marc MaillardService of Nephrology Department, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
Petra KlusonovaNational Center of Competence in Research "Kidney.CH", Lausanne, Switzerland.
Alex OdermattNational Center of Competence in Research "Kidney.CH", Lausanne, Switzerland.
Robert KoestersHôpital Tenon, Université Pierre et Marie Curie, Paris, France.
Dominique Loffing-CueniNational Center of Competence in Research "Kidney.CH", Lausanne, Switzerland.
Johannes LoffingNational Center of Competence in Research "Kidney.CH", Lausanne, Switzerland.
Bernard RossierDepartment of Pharmacology and Toxicology, University of Lausanne, Rue du Bugnon 27, CH-1011, Lausanne, Switzerland.
Simona FrateschiDepartment of Pharmacology and Toxicology, University of Lausanne, Rue du Bugnon 27, CH-1011, Lausanne, Switzerland.
Edith HummlerDepartment of Pharmacology and Toxicology, University of Lausanne, Rue du Bugnon 27, CH-1011, Lausanne, Switzerland. Edith.Hummler@unil.ch.
University Hospital of Lausanne · CHUniversity of Lausanne · CHUniversity of Zurich · CHSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aldosterone is the main mineralocorticoid hormone controlling sodium balance, fluid homeostasis, and blood pressure by regulating sodium reabsorption in the aldosterone-sensitive distal nephron (ASDN). Germline loss-of-function mutations of the mineralocorticoid receptor (MR) in humans and in mice lead to the "renal" form of type 1 pseudohypoaldosteronism (PHA-1), a case of aldosterone resistance characterized by salt wasting, dehydration, failure to thrive, hyperkalemia, and metabolic acidosis. To investigate the importance of MR in adult epithelial cells, we generated nephron-specific MR knockout mice (MR(Pax8/LC1)) using a doxycycline-inducible system. Under standard diet, MR(Pax8/LC1) mice exhibit inability to gain weight and significant weight loss compared to control mice. Interestingly, despite failure to thrive, MR(Pax8/LC1) mice survive but develop a severe PHA-1 phenotype with higher urinary Na(+) levels, decreased plasma Na(+), hyperkalemia, and higher levels of plasma aldosterone. This phenotype further worsens and becomes lethal under a sodium-deficient diet. Na(+)/Cl(-) co-transporter (NCC) protein expression and its phosphorylated form are downregulated in the MR(Pax8/LC1) knockouts, as well as the αENaC protein expression level, whereas the expression of glucocorticoid receptor (GR) is increased. A diet rich in Na(+) and low in K(+) does not restore plasma aldosterone to control levels but is sufficient to restore body weight, plasma, and urinary electrolytes. In conclusion, MR deletion along the nephron fully recapitulates the features of severe human PHA-1. ENaC protein expression is dependent on MR activity. Suppression of NCC under hyperkalemia predominates in a hypovolemic state.

Indexed as

PhenotypeAldosteroneAnimalsEpithelial CellsEpithelial Sodium ChannelsGene DeletionMiceNephronsPotassiumPseudohypoaldosteronismReceptors, GlucocorticoidReceptors, MineralocorticoidSodiumSodium Chloride SymportersWeight LossAldosteroneEpithelial Sodium ChannelsPotassiumReceptors, GlucocorticoidReceptors, MineralocorticoidSodiumSodium Chloride SymportersAldosteroneGRMRSalt-losing syndromeThiazide-sensitive Na+/Cl− co-transporter

Identifiers

PMID26762397
OpenAlexW2239083222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.